This surface packages trim, protect, hold, and redeploy decisions into reproducible routes and JSON outputs.
/reallocation-brief keeps sources, destinations, actions, and next moves readable./trim-candidates compares savings release, downside containment, and timing./redeployment-plan shows capital shift, redeployment readiness, and board alignment./api/payload exposes the reproducible capital-reallocation packet.{
"generatedAt": "2026-06-01T00:00:00Z",
"summary": {
"items": 6,
"averageSavingsReleaseScore": 56,
"averageRedeploymentReadinessScore": 75,
"averageDownsideContainmentScore": 77,
"averageTimingScore": 74,
"averageBoardAlignmentScore": 86,
"averageUrgencyScore": 73,
"trimCandidates": 1,
"protectLanes": 2,
"totalCapitalShiftMillions": 30,
"highFindings": 2,
"recommendation": "Trim duplicate procurement packaging, reallocate into the AI and revenue cores, protect identity and biotech continuity, and hold FinTech expansion until proof improves."
},
"reallocationBrief": [
{
"owner": "Procurement intelligence lead",
"audience": "Operating committee",
"action": "TRIM",
"trimSource": "Duplicate procurement wrappers and one-off trust packaging",
"reinvestTarget": "Reusable answer packs and evidence reuse core",
"recommendedMove": "Trim duplicate procurement wrappers and preserve only the reusable answer-pack and evidence core.",
"nextMove": "Approve a trim across overlapping procurement packaging and redirect the released capacity into reusable answer and trust-evidence assets."
},
{
"owner": "AI operating partner",
"audience": "Board strategy committee",
"action": "REALLOCATE_IN",
"trimSource": "Released procurement and duplicate memo capacity",
"reinvestTarget": "AI governance and agent-readiness flagship",
"recommendedMove": "Redirect released capital into the governed AI flagship rather than spread it across disconnected experiments.",
"nextMove": "Approve reallocation into AI governance, agent readiness, and memo packaging as one flagship operating system."
},
{
"owner": "Identity assurance lead",
"audience": "Risk committee",
"action": "PROTECT",
"trimSource": "Non-core identity presentation overhead",
"reinvestTarget": "Identity evidence ledger and control-plane continuity",
"recommendedMove": "Protect the identity evidence spine and harvest savings only from duplicate packaging around it.",
"nextMove": "Ring-fence the identity evidence core and cut only the duplicate review wrappers around it."
},
{
"owner": "Revenue systems partner",
"audience": "CFO operating review",
"action": "REALLOCATE_IN",
"trimSource": "Underperforming reporting backlog and low-yield experiment noise",
"reinvestTarget": "Margin leak recovery and revenue infrastructure stabilization",
"recommendedMove": "Redeploy into the highest-recovery revenue lane and let lower-yield backlog work wait.",
"nextMove": "Approve a revenue redeployment plan centered on margin leak recovery and experiment-proof reuse."
},
{
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"action": "HOLD",
"trimSource": "Expansion capital for adjacent FinTech wrappers",
"reinvestTarget": "No move until reserve, KYC, and merchant proof tighten",
"recommendedMove": "Hold FinTech expansion flat until reserve, KYC, and merchant proof become easier to defend.",
"nextMove": "Keep FinTech capital flat until reserve exposure, KYC refresh posture, and merchant review timing improve together."
},
{
"owner": "Quality systems sponsor",
"audience": "Regulated growth committee",
"action": "PROTECT",
"trimSource": "Peripheral biotech presentation work",
"reinvestTarget": "GxP, CAPA, specimen, safety, and narrative continuity",
"recommendedMove": "Protect the biotech quality system and only defer peripheral presentation work if savings are required.",
"nextMove": "Protect the biotech quality system and approve only narrow follow-on evidence improvements."
}
],
"trimCandidates": [
{
"owner": "Procurement intelligence lead",
"audience": "Operating committee",
"action": "TRIM",
"savingsReleaseScore": 92,
"downsideContainmentScore": 73,
"timingScore": 82,
"trimSource": "Duplicate procurement wrappers and one-off trust packaging",
"companyTags": [
"Procurement",
"Trust center",
"Questionnaires",
"RFP"
]
},
{
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"action": "HOLD",
"savingsReleaseScore": 48,
"downsideContainmentScore": 46,
"timingScore": 49,
"trimSource": "Expansion capital for adjacent FinTech wrappers",
"companyTags": [
"Payments",
"Treasury",
"KYC",
"Merchant risk"
]
}
],
"redeploymentPlan": [
{
"owner": "Procurement intelligence lead",
"audience": "Operating committee",
"capitalShiftMillions": 5.4,
"redeploymentReadinessScore": 78,
"boardAlignmentScore": 85,
"urgencyScore": 81,
"headline": "Procurement is the cleanest release-of-capital lane because overlap is visible and reusable proof already exists.",
"relatedSurfaces": [
"procurement.kineticgain.com",
"questionnaire.kineticgain.com",
"proofgap.kineticgain.com"
],
"requiredEvidence": [
"Procurement OS",
"Questionnaire answer studio",
"Trust center evidence room",
"Vendor proof gap monitor"
]
},
{
"owner": "AI operating partner",
"audience": "Board strategy committee",
"capitalShiftMillions": 7.8,
"redeploymentReadinessScore": 95,
"boardAlignmentScore": 94,
"urgencyScore": 76,
"headline": "AI is the strongest redeployment target because it multiplies governance, board, and buyer narratives at once.",
"relatedSurfaces": [
"scorecard.kineticgain.com",
"memo.kineticgain.com",
"watsonx.kineticgain.com"
],
"requiredEvidence": [
"AI governance scorecard",
"Executive board brief",
"Procurement-ready proof set"
]
},
{
"owner": "Identity assurance lead",
"audience": "Risk committee",
"capitalShiftMillions": 3.1,
"redeploymentReadinessScore": 69,
"boardAlignmentScore": 91,
"urgencyScore": 68,
"headline": "Identity should be protected because it keeps access, device, and remediation evidence coherent.",
"relatedSurfaces": [
"identity.kineticgain.com",
"protect.kineticgain.com",
"guest.kineticgain.com"
],
"requiredEvidence": [
"Identity risk ledger",
"Access review posture",
"Remediation queue proof"
]
},
{
"owner": "Revenue systems partner",
"audience": "CFO operating review",
"capitalShiftMillions": 6.5,
"redeploymentReadinessScore": 89,
"boardAlignmentScore": 90,
"urgencyScore": 79,
"headline": "Revenue is a strong redeployment target because the savings story is visible to a CFO immediately.",
"relatedSurfaces": [
"revenue.kineticgain.com",
"leak.kineticgain.com",
"martech.kineticgain.com"
],
"requiredEvidence": [
"Platform margin leak report",
"Revenue infrastructure scorecard",
"Benchmark waterfall"
]
},
{
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"capitalShiftMillions": 2.8,
"redeploymentReadinessScore": 54,
"boardAlignmentScore": 63,
"urgencyScore": 74,
"headline": "FinTech should hold because downside clusters are outrunning the current proof quality.",
"relatedSurfaces": [
"payments.kineticgain.com",
"treasury.kineticgain.com",
"merchant.kineticgain.com"
],
"requiredEvidence": [
"Investor diligence pack",
"Treasury signal lab",
"Merchant review posture",
"KYC queue evidence",
"Vendor replacement intelligence"
]
},
{
"owner": "Quality systems sponsor",
"audience": "Regulated growth committee",
"capitalShiftMillions": 4.2,
"redeploymentReadinessScore": 67,
"boardAlignmentScore": 92,
"urgencyScore": 62,
"headline": "Biotech should be protected because the regulated system already reads as one defensible story.",
"relatedSurfaces": [
"gxp.kineticgain.com",
"capa.kineticgain.com",
"specimen.kineticgain.com"
],
"requiredEvidence": [
"Change control board",
"CAPA ledger",
"Specimen custody proof",
"Safety signal router"
]
}
],
"riskMap": [
{
"code": "downside-cluster",
"severity": "high",
"track": "FINTECH",
"audience": "Investor diligence committee",
"message": "Downside pressure is clustering faster than the current plan contains it."
},
{
"code": "timing-fragile",
"severity": "high",
"track": "FINTECH",
"audience": "Investor diligence committee",
"message": "Timing is fragile enough that the board should sequence this move carefully rather than assume immediate execution."
},
{
"code": "thin-proof",
"severity": "medium",
"track": "FINTECH",
"audience": "Investor diligence committee",
"message": "The reallocation narrative still rests on thin proof and needs tighter evidence before approval."
},
{
"code": "trim-ready",
"severity": "medium",
"track": "PROCUREMENT_TRUST",
"audience": "Operating committee",
"message": "This lane can release capital now without breaking the board story."
},
{
"code": "protect-core",
"severity": "info",
"track": "IDENTITY_SECURITY",
"audience": "Risk committee",
"message": "This lane behaves like protected core infrastructure and should be defended from opportunistic cuts."
},
{
"code": "protect-core",
"severity": "info",
"track": "BIOTECH_DIAGNOSTICS",
"audience": "Regulated growth committee",
"message": "This lane behaves like protected core infrastructure and should be defended from opportunistic cuts."
},
{
"code": "redeploy-now",
"severity": "info",
"track": "AI_PLATFORM",
"audience": "Board strategy committee",
"message": "This lane is ready to absorb released capital in the next committee cycle."
},
{
"code": "redeploy-now",
"severity": "info",
"track": "REVENUE_SYSTEMS",
"audience": "CFO operating review",
"message": "This lane is ready to absorb released capital in the next committee cycle."
}
],
"verification": [
"Synthetic capital-reallocation data only - no live committee memos, internal forecasts, or actual budget approvals are included.",
"Savings release, redeployment readiness, downside containment, timing, board alignment, urgency, and capital-shift metrics are modeled from the sample executive-intelligence estate in this repo.",
"This surface is read-only and shows how Kinetic Gain can package trim, protect, hold, and redeploy decisions into one board-readable capital brief.",
"Company tags and track labels are synthetic design aids rather than audited market or financial signals.",
"Every route and packet is reproducible from the included sample export."
],
"sample": [
{
"id": "procurement-trim-duplicate-wrappers",
"owner": "Procurement intelligence lead",
"audience": "Operating committee",
"track": "PROCUREMENT_TRUST",
"action": "TRIM",
"trimSource": "Duplicate procurement wrappers and one-off trust packaging",
"reinvestTarget": "Reusable answer packs and evidence reuse core",
"boardQuestion": "Where can we release spend without weakening the trust story buyers already expect?",
"currentPosture": "Procurement proof is strong, but too many buyer-facing wrappers still overlap before reuse is maximized.",
"recommendedMove": "Trim duplicate procurement wrappers and preserve only the reusable answer-pack and evidence core.",
"savingsReleaseScore": 92,
"redeploymentReadinessScore": 78,
"downsideContainmentScore": 73,
"timingScore": 82,
"boardAlignmentScore": 85,
"urgencyScore": 81,
"capitalShiftMillions": 5.4,
"headline": "Procurement is the cleanest release-of-capital lane because overlap is visible and reusable proof already exists.",
"narrative": "The board can approve savings here without undermining the core trust story, as long as the released effort moves into reusable answer and evidence infrastructure.",
"nextMove": "Approve a trim across overlapping procurement packaging and redirect the released capacity into reusable answer and trust-evidence assets.",
"companyTags": [
"Procurement",
"Trust center",
"Questionnaires",
"RFP"
],
"relatedSurfaces": [
"procurement.kineticgain.com",
"questionnaire.kineticgain.com",
"proofgap.kineticgain.com"
],
"requiredEvidence": [
"Procurement OS",
"Questionnaire answer studio",
"Trust center evidence room",
"Vendor proof gap monitor"
]
},
{
"id": "ai-redeploy-governance-flagship",
"owner": "AI operating partner",
"audience": "Board strategy committee",
"track": "AI_PLATFORM",
"action": "REALLOCATE_IN",
"trimSource": "Released procurement and duplicate memo capacity",
"reinvestTarget": "AI governance and agent-readiness flagship",
"boardQuestion": "Where does released capital compound governance, diligence, and procurement leverage fastest?",
"currentPosture": "The AI governance lane already resolves into scorecards, procurement proof, and executive memos.",
"recommendedMove": "Redirect released capital into the governed AI flagship rather than spread it across disconnected experiments.",
"savingsReleaseScore": 41,
"redeploymentReadinessScore": 95,
"downsideContainmentScore": 81,
"timingScore": 88,
"boardAlignmentScore": 94,
"urgencyScore": 76,
"capitalShiftMillions": 7.8,
"headline": "AI is the strongest redeployment target because it multiplies governance, board, and buyer narratives at once.",
"narrative": "If capital is being reallocated, the AI governance flagship is the lane most likely to turn that move into visible leverage across procurement, platform, and board surfaces.",
"nextMove": "Approve reallocation into AI governance, agent readiness, and memo packaging as one flagship operating system.",
"companyTags": [
"IBM",
"Azure",
"OpenAI",
"MCP"
],
"relatedSurfaces": [
"scorecard.kineticgain.com",
"memo.kineticgain.com",
"watsonx.kineticgain.com"
],
"requiredEvidence": [
"AI governance scorecard",
"Executive board brief",
"Procurement-ready proof set"
]
},
{
"id": "identity-protect-control-spine",
"owner": "Identity assurance lead",
"audience": "Risk committee",
"track": "IDENTITY_SECURITY",
"action": "PROTECT",
"trimSource": "Non-core identity presentation overhead",
"reinvestTarget": "Identity evidence ledger and control-plane continuity",
"boardQuestion": "Which lane should be protected because it carries trust for multiple exposure narratives at once?",
"currentPosture": "Identity proof is live across review, posture, and entitlement lanes, but it still acts as one control spine.",
"recommendedMove": "Protect the identity evidence spine and harvest savings only from duplicate packaging around it.",
"savingsReleaseScore": 53,
"redeploymentReadinessScore": 69,
"downsideContainmentScore": 89,
"timingScore": 72,
"boardAlignmentScore": 91,
"urgencyScore": 68,
"capitalShiftMillions": 3.1,
"headline": "Identity should be protected because it keeps access, device, and remediation evidence coherent.",
"narrative": "The board does not benefit from cutting the lane that underwrites access, posture, and remediation trust. Protect the core and only trim duplicate shells.",
"nextMove": "Ring-fence the identity evidence core and cut only the duplicate review wrappers around it.",
"companyTags": [
"CyberArk",
"Okta",
"Entra",
"Intune"
],
"relatedSurfaces": [
"identity.kineticgain.com",
"protect.kineticgain.com",
"guest.kineticgain.com"
],
"requiredEvidence": [
"Identity risk ledger",
"Access review posture",
"Remediation queue proof"
]
},
{
"id": "revenue-redeploy-margin-recovery",
"owner": "Revenue systems partner",
"audience": "CFO operating review",
"track": "REVENUE_SYSTEMS",
"action": "REALLOCATE_IN",
"trimSource": "Underperforming reporting backlog and low-yield experiment noise",
"reinvestTarget": "Margin leak recovery and revenue infrastructure stabilization",
"boardQuestion": "Which revenue lane best converts released capital into visible savings and cleaner growth math?",
"currentPosture": "Revenue infrastructure already exposes leak recovery, experiment proof, and reporting-path uplift.",
"recommendedMove": "Redeploy into the highest-recovery revenue lane and let lower-yield backlog work wait.",
"savingsReleaseScore": 64,
"redeploymentReadinessScore": 89,
"downsideContainmentScore": 77,
"timingScore": 84,
"boardAlignmentScore": 90,
"urgencyScore": 79,
"capitalShiftMillions": 6.5,
"headline": "Revenue is a strong redeployment target because the savings story is visible to a CFO immediately.",
"narrative": "This is the easiest capital-rotation story to tell finance: pull effort from low-yield reporting noise and redirect into the lane that already recovers margin.",
"nextMove": "Approve a revenue redeployment plan centered on margin leak recovery and experiment-proof reuse.",
"companyTags": [
"Klaviyo",
"VWO",
"Power BI",
"Tableau"
],
"relatedSurfaces": [
"revenue.kineticgain.com",
"leak.kineticgain.com",
"martech.kineticgain.com"
],
"requiredEvidence": [
"Platform margin leak report",
"Revenue infrastructure scorecard",
"Benchmark waterfall"
]
},
{
"id": "fintech-hold-until-proof-clears",
"owner": "FinTech diligence lead",
"audience": "Investor diligence committee",
"track": "FINTECH",
"action": "HOLD",
"trimSource": "Expansion capital for adjacent FinTech wrappers",
"reinvestTarget": "No move until reserve, KYC, and merchant proof tighten",
"boardQuestion": "Where should the board hold capital steady until downside clusters and proof fragmentation improve?",
"currentPosture": "Payments, KYC, treasury, and merchant review are live, but the story still clusters across multiple risk motions.",
"recommendedMove": "Hold FinTech expansion flat until reserve, KYC, and merchant proof become easier to defend.",
"savingsReleaseScore": 48,
"redeploymentReadinessScore": 54,
"downsideContainmentScore": 46,
"timingScore": 49,
"boardAlignmentScore": 63,
"urgencyScore": 74,
"capitalShiftMillions": 2.8,
"headline": "FinTech should hold because downside clusters are outrunning the current proof quality.",
"narrative": "The disciplined answer is not to cut the lane, but to stop feeding expansion capital into it until reserve, KYC, and merchant review evidence get tighter.",
"nextMove": "Keep FinTech capital flat until reserve exposure, KYC refresh posture, and merchant review timing improve together.",
"companyTags": [
"Payments",
"Treasury",
"KYC",
"Merchant risk"
],
"relatedSurfaces": [
"payments.kineticgain.com",
"treasury.kineticgain.com",
"merchant.kineticgain.com"
],
"requiredEvidence": [
"Investor diligence pack",
"Treasury signal lab",
"Merchant review posture",
"KYC queue evidence",
"Vendor replacement intelligence"
]
},
{
"id": "biotech-protect-quality-system",
"owner": "Quality systems sponsor",
"audience": "Regulated growth committee",
"track": "BIOTECH_DIAGNOSTICS",
"action": "PROTECT",
"trimSource": "Peripheral biotech presentation work",
"reinvestTarget": "GxP, CAPA, specimen, safety, and narrative continuity",
"boardQuestion": "Which regulated lane already behaves like one working operating system and should be defended from opportunistic cuts?",
"currentPosture": "GxP, CAPA, specimen, safety, and narrative review now read as one coherent regulated stack.",
"recommendedMove": "Protect the biotech quality system and only defer peripheral presentation work if savings are required.",
"savingsReleaseScore": 39,
"redeploymentReadinessScore": 67,
"downsideContainmentScore": 93,
"timingScore": 71,
"boardAlignmentScore": 92,
"urgencyScore": 62,
"capitalShiftMillions": 4.2,
"headline": "Biotech should be protected because the regulated system already reads as one defensible story.",
"narrative": "The mistake would be harvesting short-term savings from the one regulated lane that already behaves like a mature operating layer.",
"nextMove": "Protect the biotech quality system and approve only narrow follow-on evidence improvements.",
"companyTags": [
"GxP",
"CAPA",
"Specimen",
"Safety"
],
"relatedSurfaces": [
"gxp.kineticgain.com",
"capa.kineticgain.com",
"specimen.kineticgain.com"
],
"requiredEvidence": [
"Change control board",
"CAPA ledger",
"Specimen custody proof",
"Safety signal router"
]
}
]
}